메뉴 건너뛰기




Volumn 8, Issue 7, 2013, Pages

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; EPITHELIAL CELL ADHESION MOLECULE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; SORAFENIB;

EID: 84880842525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070010     Document Type: Article
Times cited : (73)

References (33)
  • 2
    • 84864465226 scopus 로고    scopus 로고
    • Clinical implications of cancer stem cell biology in hepatocellular carcinoma
    • Ji J, Wang XW, (2012) Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 39: 461-472.
    • (2012) Semin Oncol , vol.39 , pp. 461-472
    • Ji, J.1    Wang, X.W.2
  • 3
    • 52549087785 scopus 로고    scopus 로고
    • Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
    • Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
    • (2008) Nat Rev Cancer , vol.8 , pp. 755-768
    • Visvader, J.E.1    Lindeman, G.J.2
  • 5
    • 0034773404 scopus 로고    scopus 로고
    • Role of AMP-activated protein kinase in mechanism of metformin action
    • Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1184.
    • (2001) J Clin Invest , vol.108 , pp. 1167-1184
    • Zhou, G.1    Myers, R.2    Li, Y.3    Chen, Y.4    Shen, X.5
  • 7
    • 33645766204 scopus 로고    scopus 로고
    • Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
    • Bowker SL, Majumdar SR, Veugelers P, Johnson JA, (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29: 254-258.
    • (2006) Diabetes Care , vol.29 , pp. 254-258
    • Bowker, S.L.1    Majumdar, S.R.2    Veugelers, P.3    Johnson, J.A.4
  • 9
    • 15544382574 scopus 로고    scopus 로고
    • Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
    • Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB, (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54: 533-539.
    • (2005) Gut , vol.54 , pp. 533-539
    • Davila, J.A.1    Morgan, R.O.2    Shaib, Y.3    McGlynn, K.A.4    El-Serag, H.B.5
  • 10
    • 77954365681 scopus 로고    scopus 로고
    • Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
    • Donadon V, Balbi M, Mas MD, Casarin P, Zanette G, (2010) Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 30: 750-758.
    • (2010) Liver Int , vol.30 , pp. 750-758
    • Donadon, V.1    Balbi, M.2    Mas, M.D.3    Casarin, P.4    Zanette, G.5
  • 11
    • 79954478103 scopus 로고    scopus 로고
    • Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation
    • Chen TM, Lin CC, Huang PT, Wen CF, (2011) Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation. J Gastroenterol Hepatol 26: 858-865.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 858-865
    • Chen, T.M.1    Lin, C.C.2    Huang, P.T.3    Wen, C.F.4
  • 12
    • 60449087921 scopus 로고    scopus 로고
    • EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features
    • Yamashita T, Ji J, Budhu A, Forgues M, Yang W, et al. (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136: 1012-1024.
    • (2009) Gastroenterology , vol.136 , pp. 1012-1024
    • Yamashita, T.1    Ji, J.2    Budhu, A.3    Forgues, M.4    Yang, W.5
  • 13
    • 34249980343 scopus 로고    scopus 로고
    • Identification and characterization of tumorigenic liver cancer stem/progenitor cells
    • Ma S, Chan KW, Hu L, Lee TK, Wo JY, et al. (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556.
    • (2007) Gastroenterology , vol.132 , pp. 2542-2556
    • Ma, S.1    Chan, K.W.2    Hu, L.3    Lee, T.K.4    Wo, J.Y.5
  • 14
    • 84865131639 scopus 로고    scopus 로고
    • In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
    • Qu Z, Zhang Y, Liao M, Chen Y, Zhao J, et al. (2012) In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma. Hepatol Res 42: 922-933.
    • (2012) Hepatol Res , vol.42 , pp. 922-933
    • Qu, Z.1    Zhang, Y.2    Liao, M.3    Chen, Y.4    Zhao, J.5
  • 15
    • 84867405520 scopus 로고    scopus 로고
    • Metformin targets ovarian cancer stem cells in vitro and in vivo
    • Shank JJ, Yang K, Ghannam J, Cabrera L, Johnston CJ, et al. (2012) Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol 127: 390-397.
    • (2012) Gynecol Oncol , vol.127 , pp. 390-397
    • Shank, J.J.1    Yang, K.2    Ghannam, J.3    Cabrera, L.4    Johnston, C.J.5
  • 16
    • 70350236538 scopus 로고    scopus 로고
    • Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
    • Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K, (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69: 7507-7511.
    • (2009) Cancer Res , vol.69 , pp. 7507-7511
    • Hirsch, H.A.1    Iliopoulos, D.2    Tsichlis, P.N.3    Struhl, K.4
  • 17
    • 33746565515 scopus 로고    scopus 로고
    • Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway
    • Gollob JA, Wilhelm S, Carter C, Kelley SL, (2006) Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol 33: 392-406.
    • (2006) Semin Oncol , vol.33 , pp. 392-406
    • Gollob, J.A.1    Wilhelm, S.2    Carter, C.3    Kelley, S.L.4
  • 18
    • 33646376411 scopus 로고    scopus 로고
    • Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
    • Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, et al. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475-482.
    • (2006) Nature , vol.441 , pp. 475-482
    • Yilmaz, O.H.1    Valdez, R.2    Theisen, B.K.3    Guo, W.4    Ferguson, D.O.5
  • 19
    • 36048963331 scopus 로고    scopus 로고
    • Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
    • Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, et al. (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 104: 16158-16163.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 16158-16163
    • Zhou, J.1    Wulfkuhle, J.2    Zhang, H.3    Gu, P.4    Yang, Y.5
  • 20
    • 58549108859 scopus 로고    scopus 로고
    • The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
    • Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, et al. (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A 106: 268-273.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 268-273
    • Dubrovska, A.1    Kim, S.2    Salamone, R.J.3    Walker, J.R.4    Maira, S.M.5
  • 23
    • 80555126830 scopus 로고    scopus 로고
    • Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
    • Zhu AX, Abrams TA, Miksad R, Blaszkowsky LS, Meyerhardt JA, et al. (2011) Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer 117: 5094-5102.
    • (2011) Cancer , vol.117 , pp. 5094-5102
    • Zhu, A.X.1    Abrams, T.A.2    Miksad, R.3    Blaszkowsky, L.S.4    Meyerhardt, J.A.5
  • 24
    • 77949484645 scopus 로고    scopus 로고
    • Rapamycin inhibits proliferation and migration of hepatoma cells in vitro
    • Shirouzu Y, Ryschich E, Salnikova O, Kerkadze V, Schmidt J, et al. (2010) Rapamycin inhibits proliferation and migration of hepatoma cells in vitro. J Surg Res 159: 705-713.
    • (2010) J Surg Res , vol.159 , pp. 705-713
    • Shirouzu, Y.1    Ryschich, E.2    Salnikova, O.3    Kerkadze, V.4    Schmidt, J.5
  • 26
    • 0346362997 scopus 로고    scopus 로고
    • Rapamycins: mechanism of action and cellular resistance
    • Huang S, Bjornsti MA, Houghton PJ, (2003) Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther 2: 222-232.
    • (2003) Cancer Biol Ther , vol.2 , pp. 222-232
    • Huang, S.1    Bjornsti, M.A.2    Houghton, P.J.3
  • 27
    • 58149354390 scopus 로고    scopus 로고
    • Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1
    • Zhuang Y, Miskimins WK, (2008) Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 3: 18.
    • (2008) J Mol Signal , vol.3 , pp. 18
    • Zhuang, Y.1    Miskimins, W.K.2
  • 28
    • 84874660234 scopus 로고    scopus 로고
    • Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
    • Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, et al. (2013) Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut 62: 606-615.
    • (2013) Gut , vol.62 , pp. 606-615
    • Chen, H.P.1    Shieh, J.J.2    Chang, C.C.3    Chen, T.T.4    Lin, J.T.5
  • 29
    • 84872529696 scopus 로고    scopus 로고
    • Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
    • Hirsch HA, Iliopoulos D, Struhl K, (2013) Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci U S A 110: 972-977.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 972-977
    • Hirsch, H.A.1    Iliopoulos, D.2    Struhl, K.3
  • 30
    • 84873707522 scopus 로고    scopus 로고
    • Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
    • Miller RA, Chu Q, Xie J, Foretz, Viollet B, et al. (2013) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494: 256-260.
    • (2013) Nature , vol.494 , pp. 256-260
    • Miller, R.A.1    Chu, Q.2    Xie, J.3    Foretz, V.B.4
  • 31
    • 57749189578 scopus 로고    scopus 로고
    • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    • Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, et al. (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10: 25-34.
    • (2009) Lancet Oncol , vol.10 , pp. 25-34
    • Cheng, A.L.1    Kang, Y.K.2    Chen, Z.3    Tsao, C.J.4    Qin, S.5
  • 32
    • 47949116252 scopus 로고    scopus 로고
    • SHARP Investigators Study Group, Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, et al. (2008) SHARP Investigators Study Group, Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390.
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3    Hilgard, P.4    Gane, E.5
  • 33
    • 34547803161 scopus 로고    scopus 로고
    • Human hepatic stem cells from fetal and postnatal donors
    • Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, et al. (2007) Human hepatic stem cells from fetal and postnatal donors. J Exp Med 204: 1973-1987.
    • (2007) J Exp Med , vol.204 , pp. 1973-1987
    • Schmelzer, E.1    Zhang, L.2    Bruce, A.3    Wauthier, E.4    Ludlow, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.